Psilocybin, the hallucinogen found in "magic mushrooms," may help relieve depressive episodes in people with bipolar disorder, without triggering mania or mood swings like some common antidepressants ...
Grace Kemmerly ‘25, a Biochemistry major with co-majors in both Premedical Studies and Neuroscience, knew she wanted to get involved in undergraduate research after hearing about the groundbreaking ...
Share on Pinterest A new study compared psilocybin with a common SSRI and found that both drugs improved symptoms, while psilocybin provided added benefits. Maki Nakamura/Getty Images A new study ...
Psyence BioMed Announces Approval for Use of PsyLabs’ Psilocybin Product in Phase IIb Clinical Trial
NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine ...
Clinical Trials Arena on MSN
Psyence gains HREC nod to use PsyLabs’ psilocybin in adjustment disorder trial
With several sites activated and recruitment ongoing, the Phase IIb trial is projected to deliver top-line outcomes next year.
A new study from Emory University suggests that psilocybin, the active compound in magic mushrooms, may extend your lifespan. Scientists at the university’s department of medicine in Atlanta ...
Psilocybe cyanescens mushrooms, which contain the active compound, psilocybin. Credit: Imperial College London / Thomas Angus Psilocybin, the active compound in magic mushrooms, may be at least as ...
Use of psilocybin—the psychedelic compound found in "magic mushrooms"—has risen across the U.S. in all ages groups since the drug was partially decriminalized in 2019. The hallucinogen was ...
A new analysis of clinical trial data indicates that psilocybin, when administered alongside psychotherapy, may provide rapid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback